A recombinant influenza A virus expressing domain III of West Nile virus induces protective immune responses against influenza and West Nile virus
about
Recent progress in West Nile virus diagnosis and vaccinationProtective immunity and safety of a genetically modified influenza virus vaccineImmunogenicity of a West Nile virus DIII-cholera toxin A2/B chimera after intranasal deliveryA VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice.Vaccination strategies against highly pathogenic arenaviruses: the next steps toward clinical trialsIdentification of class I HLA T cell control epitopes for West Nile virusA recombinant novirhabdovirus presenting at the surface the E Glycoprotein from West Nile Virus (WNV) is immunogenic and provides partial protection against lethal WNV challenge in BALB/c mice.Induction of protective CD4+ T cell-mediated immunity by a Leishmania peptide delivered in recombinant influenza viruses.Induction of antigen-specific immune responses in mice by recombinant baculovirus expressing premembrane and envelope proteins of West Nile virus.An inactivated cell culture Japanese encephalitis vaccine (JE-ADVAX) formulated with delta inulin adjuvant provides robust heterologous protection against West Nile encephalitis via cross-protective memory B cells and neutralizing antibodyRecent advances in molecular medicine techniques for the diagnosis, prevention, and control of infectious diseases.Technologies for the development of West Nile virus vaccines.Epitope-specific CD4+, but not CD8+, T-cell responses induced by recombinant influenza A viruses protect against Mycobacterium tuberculosis infection.Mosaic RNA phage VLPs carrying domain III of the West Nile virus E protein.
P2860
Q21284433-58BEAF91-F988-4EED-B363-7E386F08E4DEQ27324763-BD2AB03D-E683-4240-B8B5-A79369EC7C5CQ33584872-294E420B-4453-4EB8-9CBE-74237191EF58Q34039347-350096B6-ED00-40A7-8465-A57174697DF8Q34671806-0891A386-0E6B-4DFF-84B6-5DE5BB0F9752Q34770618-60155FFA-2D84-46BC-B170-736B51EC8B93Q35129151-3ABF6AE9-D6EF-414C-B796-64A6EA5DF289Q35845737-1FB6C1B3-E8EC-4ACA-92E2-7329A64680A2Q36179005-73655B62-EC21-4CFE-825D-EAFC17108537Q37123147-69784B93-1D56-41EB-B4CD-18CEBA62EE41Q38075857-3FE3235E-8DE7-40A3-8CCD-4B589261D1B6Q38269151-8EC4D046-6058-4081-8C28-668E10E108AFQ41645299-3E627967-ECB5-41EE-A57F-EB61619DA7E5Q42235222-8ED27805-8B78-4DFB-B162-5DA39CB152CA
P2860
A recombinant influenza A virus expressing domain III of West Nile virus induces protective immune responses against influenza and West Nile virus
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A recombinant influenza A viru ...... influenza and West Nile virus
@ast
A recombinant influenza A viru ...... influenza and West Nile virus
@en
A recombinant influenza A viru ...... influenza and West Nile virus
@nl
type
label
A recombinant influenza A viru ...... influenza and West Nile virus
@ast
A recombinant influenza A viru ...... influenza and West Nile virus
@en
A recombinant influenza A viru ...... influenza and West Nile virus
@nl
prefLabel
A recombinant influenza A viru ...... influenza and West Nile virus
@ast
A recombinant influenza A viru ...... influenza and West Nile virus
@en
A recombinant influenza A viru ...... influenza and West Nile virus
@nl
P2093
P2860
P50
P1433
P1476
A recombinant influenza A viru ...... influenza and West Nile virus
@en
P2093
Byron E E Martina
Geert van Amerongen
Gunther Spohn
Lisette B V Provacia
Penelope Koraka
Petra van den Doel
P2860
P304
P356
10.1371/JOURNAL.PONE.0018995
P407
P577
2011-04-26T00:00:00Z